What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients?

Peritoneal Dialysis International

Volumn 26, Issue 3, 2006, Pages 336-340

  Jeloka, Tarun K ^a   Ersoy, Fevzi F ^b   Yavuz, Mahmut ^c   Sahu, Krishna M ^a   Çamsari, Taner ^d   Utaş, Cengiz ^e   Bozfakioglu, Semra ^f   Özener, Çetin ^g   Ateş, Kenan ^h   Ataman, Rezzan ⁱ   Akçiçek, Fehmi ^j   Akpolat, Tekin ^k   Karayaylali, Ibrahim ^l   Arinsoy, Turgay ^m   Mehmet, Emin Yilmaz ⁿ   Süleymanlar, Gültekin ^b   Burdzy, Dorothy ^a   Oreopoulos, Dimitrios G ^a,o  

^a UNIVERSITY OF TORONTO   (Canada)

^b AKDENIZ UNIVERSITY   (Turkey)

^c ULUDAG UNIVERSITY   (Turkey)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e ERCIYES UNIVERSITY   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

^g MARMARA UNIVERSITY   (Turkey)

^h ANKARA UNIVERSITY   (Turkey)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

^j EGE UNIVERSITY   (Turkey)

^k ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^l CUKUROVA UNIVERSITY   (Turkey)

^m GAZI UNIVERSITY   (Turkey)

ⁿ DICLE UNIVERSITY   (Turkey)

^o TORONTO WESTERN HOSPITAL   (Canada)

more..

Author keywords

Automated peritoneal dialysis; Icodextrin; Ultrafiltration

Indexed keywords

CREATININE; ICODEXTRIN; PERITONEAL DIALYSIS FLUID;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CANADA; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CLINICAL TRIAL; CREATININE CLEARANCE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME; TURKEY (REPUBLIC); ULTRAFILTRATION;

EID: 33748428468     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600310     Document Type: Article

References (18)

1. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948-57.
2. Wilkie ME, Plant MJ, Edwards L, Brown CB. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17:84-7.
3. Mistry CD, Mallick NP, Gokal R. Ultrafiltration with an isosmolar solution during long PD exchanges. Lancet 1987; ii:178-82.
4. Mistry CD, Gokal R, Peers E, MIDAS Study Group. Randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solution in CAPD. Kidney Int 1994; 46:496-503.
5. Davies SJ, Phillips L, Naish PF, Russell G. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
6. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2:2.
7. Wolfson M, Piraino B, Hamburger J, Morton AR, for the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
8. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al., on behalf of the Icodextrin High Transporter Trial Group. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
9. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14:1530-5.
10. Posthuma N, Wee PM, Donker AJM, Oe PL, Peers EM, Verburgh HA [The Dextrin in APD in Amsterdam (DIANA) Group]. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 2):S106-13.
11. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997; 12:550-3.
12. Bajo MA, Selgas R, del Peso G, Castro MJ, Hevia C, Gil F, et al. Use of icodextrin for diurnal exchange in patients undergoing automated peritoneal dialysis. Comparison with glucose solutions [in Spanish]. Nefrologia 2002; 22: 348-55.
13. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39: 862-71.
14. Krishnan M, Laikopoulos V, Passadakis P, Oreopoulos DG. Low ultrafiltration with icodextrin after prolonged dwells (14-15 hours) with significant intra and inter-patient variation [Abstract]. J Am Soc Nephrol 2003; 14:481A.
15. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57:2546-56.
16. Neri L, Viglino G, Cappelletti A, Gandolfo C, Cavalli PL. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Adv Perit Dial 2000; 16:174-6.
17. Araujo Teixeira MR, Pecoits Filho RF, Romao JE, Sabbaga E, Marcondes MM, Abensur H. The relationship between ultrafiltration volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 2002; 22:229-33.
18. Wiggins KJ, Rumpsfeld M, Blizzard S, Johnson DW. Predictors of a favorable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure. Nephrology 2005; 10:33-6.